DATASHEET
Host:
Rabbit
Target Protein:
CBL
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
867
Source:
KLH conjugated synthetic peptide derived from human CBL2
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Store at -20°C for 12 months.
Background:
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Mar 2012]
VALIDATION IMAGES
Formalin-fixed and paraffin embedded mouse tumor labeled with Anti CBL2 Polyclonal Antibody, Unconjugated (bs-2757R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Lane 1: Mouse Raw264.7 cell lysates; Lane 2: Mouse Thymus tissue lysates; Lane 3: Mouse Testis tissue lysates; Lane 4: Rat Testis tissue lysates; Lane 5: Human K562 cell lysates; Lane 6: Human Daudi cell lysates; Lane 7: Human MCF-7 cell lysates; Lane 8: Human Jurkat cell lysates probed with CBL Polyclonal Antibody, Unconjugated (bs-2757R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at room temperature for 60 min.